Regenerative Insider Brief - March 2026

1. Low-Intensity Infrared Light Extends Lifespan by 60% in Studies

A bioRxiv preprint showed that precisely tuned, ultra-low-intensity 34 THz mid-infrared (MIR) light, far too weak to generate heat, extended median lifespan in C. elegans by 60% (from ~10 to 16 days). The secret? Resonant absorption matching vibrational frequencies of phosphate groups in DNA, RNA, and mitochondrial membranes. This boosted gene transcription, optimized mitochondrial energy production, reduced fragmentation, and delayed aging onset without triggering stress responses.

This physical, drug-free approach points to future wearable or in-clinic light therapies that enhance cellular efficiency at the molecular level. It could amplify skin resilience and whole-body vitality for those dealing with oxidative stress. Early days for humans, but the resonance science is elegant and worth watching for photobiomodulation integrations.

Source: https://www.biorxiv.org/content/10.64898/2026.02.08.704722v2.full-text

2. Blocking an Aging Protein Reverses Damage in Primates and Rats

Mid-March posts exploded over research on HMGB1 (high-mobility group box 1), a protein secreted by senescent cells that acts like a bloodstream “aging broadcast.” Using the non-inflammatory Box A domain (via plasmid or gene therapy), scientists restored youthful plasma proteomics in perimenopausal monkeys, slashed senescence markers, and reversed Alzheimer’s-like neuropathology (amyloid-β and tau) in rat models.

Aging isn’t just cellular wear-and-tear—it’s a transmissible signal we can interrupt. This points to future therapies that treat aging as a modifiable disease. Promising for frailty, neurodegeneration, and even skin health via reduced systemic inflammation. High-engagement X threads called it proof that “blocking one protein literally reversed the damage.”

Source: https://www.nature.com/articles/s41598-026-46747-9

3. First Human Trial of Epigenetic Reprogramming for Vision Loss Begins

The biggest headline of the month: FDA-cleared enrollment ramp for Life Biosciences’ ER-100, the world’s first-in-human trial of transient partial reprogramming (OSK factors) to reset epigenetic age without full dedifferentiation. Targeting optic neuropathies like glaucoma and “stroke of the eye,” this builds directly on David Sinclair’s primate work showing restored youthful gene expression and vision recovery.

This trial marks the shift from mouse miracles to human reality. Partial reprogramming could one day extend to broader regenerative aesthetics, skin rejuvenation, and whole-body healthspan. We’re tracking this closely as the blueprint for next-gen therapies.

Source: https://www.lifebiosciences.com/life-biosciences-announces-fda-clearance-of-ind-application-for-er-100-in-optic-neuropathies/

4. Space-Tech Serum Delivers Strong Results for Skin Firmness and Radiance

Dermatology Times’ March edition spotlighted Delavie Sciences’ Aeonia serum, powered by patented Bacillus Lysate (ISS space-tech origin). In 8-week trials, it delivered immediate +39% elasticity, +15–75% radiance, +52% smoothness, and up to 53% reduction in fine lines/wrinkles while activating sirtuins (longevity enzymes), slashing UVA radicals, and skyrocketing hyaluronic acid production. 100% of users reported visibly healthier, more youthful skin.

The marketing spin: This isn’t just another cream, it’s regenerative aesthetics meeting longevity science, embedding proven sirtuin and extracellular matrix pathways. Supporting endogenous hyaluronic acid and sirtuin activity delivers real results without downtime. We’re already seeing similar peptide-marine tech trends, and this one stands out.

Source: https://www.delaviesciences.com/products/aeonia-age-defying-serum

Note: We asked Gemini: “Please compare Aeonia and AnteAGE MD Serum for effectiveness when used daily on aging skin from both a formulation and price standpoint.”

Response: From a formulation standpoint, AnteAGE MD Serum utilizes medical-grade human bone marrow-derived stem cell cytokines and growth factors to communicate with skin cells for deep regenerative repair. In contrast, Aeonia Age Defying Serum relies on Bacillus Lysate, a space-certified biotechnology designed to activate longevity proteins (Sirt1) and boost the skin’s natural hyaluronic acid production. Both formulas are highly effective for aging skin, but AnteAGE MD is often preferred for inflammatory modulation and post-procedure healing, while Aeonia focuses on antioxidant defense and daily luminosity. From a price perspective, Aeonia is the more accessible option at approximately $125, whereas AnteAGE MD Serum is a premium medical-grade investment typically priced around $190 to $200.

If you are looking for a high-performance daily serum to boost hydration and glow, Aeonia Age Defying Serum offers an innovative, science-backed approach at a lower price point. However, for those seeking the most advanced regenerative “command and control” technology to target deep wrinkles and skin health at a cellular level, AnteAGE MD Serum is the industry standard.

5. Stem Cell Therapy Shows Real Progress in Reversing Frailty

Mid-March updates on Longeveron’s Lomecel-B (single infusion of donor-derived MSCs) in 70–85-year-olds with frailty were electric on X. Nearly one-third of treated patients were no longer frail at 9 months; best-dose groups gained ~63 meters in 6-minute walk tests versus placebo. Mechanism: reduced inflammation + enhanced tissue repair.

Functional decline is one of the most honest measures of aging. Results like these validate the regenerative approach: supporting the body’s repair systems rather than fighting symptoms in isolation. Clinicians on X called it “one of the most promising human trials yet for actually reversing age-related decline.”

Source: https://www.sciencedirect.com/science/article/abs/pii/S1934590926000408